The Centers for Medicare & Medicaid Services this week awarded 14 states and the District of Columbia planning grants totaling $48.5 million to increase access to evidence-based treatment and recovery services for Medicaid patients with substance use disorders. Alabama, Connecticut, Delaware, the District of Columbia, Illinois, Indiana, Kentucky, Maine, Michigan, Nevada, New Mexico, Rhode Island, Virginia, Washington and West Virginia will use the grants to assess state needs, recruit and train providers, and improve reimbursement to expand treatment capacity. Section 1003 of the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorized the planning grants for a demonstration project to increase Medicaid provider capacity to treat SUDs. CMS will select up to five of the states to receive an enhanced federal matching rate for SUD services for three years under the project.

Related News Articles

Headline
The Medicaid and CHIP Payment and Access Commission (MACPAC) June 11 released its June report to Congress. The first chapter focuses on improving the…
Headline
Chris DeRienzo, M.D., AHA senior vice president and chief physician executive, speaks with three experts about how the award-winning Women and Infant Substance…
Headline
A report released May 29 by the Government Accountability Office found a lack of state oversight on Medicaid managed care plans’ use of prior authorization for…
Headline
The Centers for Medicare & Medicaid Services is seeking public comments until July 22 on the information requirements associated with attestation…
Headline
The Centers for Medicare & Medicaid Services recently announced the approval of Delaware and Tennessee as the first states to provide diapers to children…
Headline
The Centers for Medicare & Medicaid Services May 9 announced an extension of unwinding flexibilities to support state efforts to protect the continuity of…